The movement into a CHO cell line is definitely not negative news by any means. On the contrary, it is normal to research a drug in a cell line that is high expressing before moving expression into a more suitable cell line such as CHO for large-scale production.
this news is mildly interesting. I don't hold. yet.
All IMO, dyor.
PAB Price at posting:
2.9¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)